Search

Repligen Corp

Закрыт

СекторЗдравоохранение

164.39 0.31

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

163.59

Макс.

167.49

Ключевые показатели

By Trading Economics

Доход

-3.3M

5M

Продажи

9.9M

204M

P/E

Средняя по отрасли

226.487

56.597

Прибыль на акцию

0.54

Рентабельность продаж

2.453

Сотрудники

2,000

EBITDA

-35M

-2.4M

Дивиденды

By Acuity

Следующий отчет о доходах

27 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

2.1B

9.5B

Предыдущая цена открытия

164.08

Предыдущая цена закрытия

164.39

Новостные настроения

By Acuity

75%

25%

307 / 339 Рейтинг в Healthcare

Repligen Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 сент. 2026 г., 21:01 UTC

Repligen Corp shares are higher in after-market trading, continuing an upward trend since Friday's close. The stock remains below its 20-day moving average.

10 сент. 2026 г., 20:07 UTC

Repligen Corp shares are lower amid broader market declines following the European Central Bank's interest rate hike and rising Treasury yields.

9 сент. 2026 г., 20:07 UTC

Repligen Corp shares are lower during Wednesday's session, with no specific news identified. The stock remains significantly below its 20-day moving average.

8 сент. 2026 г., 22:21 UTC

Repligen Corp shares declined in after-market trading, falling further from Tuesday's close and remaining near the lower end of their one-month trading range.

2 сент. 2026 г., 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

1 сент. 2026 г., 20:01 UTC

Repligen Corp shares are lower today, continuing a decline from Monday's close amid rising oil prices and inflation concerns affecting market conditions.

31 авг. 2026 г., 21:02 UTC

Repligen Corp shares are lower in after-market hours amid broader economic concerns and hawkish comments from Fed Chair Kevin Warsh on inflation and interest rates.

28 авг. 2026 г., 23:01 UTC

Repligen Corp shares are higher in after-market hours, reflecting strong momentum and positioning near the upper end of their one-month trading range.

26 авг. 2026 г., 19:46 UTC

News

Repligen Corp shares are lower during Wednesday's session amid broader market volatility and persistent inflationary pressures reflected in recent PCE data.

25 авг. 2026 г., 22:01 UTC

Repligen Corp shares are lower in after-market trading, reflecting broader market caution ahead of key economic events and a drop in consumer confidence.

24 авг. 2026 г., 19:36 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock showed volatility, peaking earlier in the session.

21 авг. 2026 г., 22:31 UTC

Correlated Moves

Repligen Corp's after-market performance is roughly flat, reflecting a slight decline since Friday's close amid broader market weakness in the life sciences sector.

20 авг. 2026 г., 19:51 UTC

Repligen Corp is gaining during Thursday's session, supported by strong movement in the Life Sciences Tools & Services sub-sector. Shares pulled back earlier but have advanced.

19 авг. 2026 г., 20:02 UTC

Repligen Corp is advancing sharply, supported by gains in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

18 авг. 2026 г., 19:36 UTC

Repligen Corp shares are declining, continuing a downward trend since Monday. Broader market sentiment remains cautious amid rising treasury yields and inflation concerns.

14 авг. 2026 г., 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13 авг. 2026 г., 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12 авг. 2026 г., 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11 авг. 2026 г., 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10 авг. 2026 г., 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7 авг. 2026 г., 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6 авг. 2026 г., 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5 авг. 2026 г., 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4 авг. 2026 г., 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31 июл. 2026 г., 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30 июл. 2026 г., 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29 июл. 2026 г., 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28 июл. 2026 г., 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27 июл. 2026 г., 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

24 июл. 2026 г., 19:06 UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

Сравнение c конкурентами

Изменение цены

Repligen Corp Прогноз

Консенсус по рейтингу

By TipRanks

Активная покупка

11 ratings

10

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

307 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat